Health services utilization, work absenteeism and costs of pandemic influenza A (H1N1) 2009 in Spain: a multicenter-longitudinal study.

PloS One
Mariana GalanteJordi Alonso

Abstract

The aim of this study was to estimate healthcare resource utilization, work absenteeism and cost per patient with pandemic influenza (H1N1)2009, from its beginning to March 2010, in Spain. We also estimated the economic impact on healthcare services. Longitudinal, descriptive, multicenter study of in- and outpatients with confirmed diagnosis of influenza A (H1N1) in Spain. Temporal distribution of cases was comparable to that in Spain. Information of healthcare and social resources used from one week before admission (inpatient) or index-medical visit (outpatient) until recovery was gathered. Unit cost was imputed to utilization frequency for the monetary valuation of use. Mean cost per patient was calculated. A sensitivity analysis was conducted, and variables correlated with cost per patient were identified. Economic impact on the healthcare system was estimated using healthcare costs per patient and both, the reported number of confirmed and clinical cases in Spain. 172 inpatients and 224 outpatients were included. Less than 10% were over 65 years old and more than 50% had previous comorbidities. 12.8% of inpatients were admitted to the Intensive Care Unit. Mean length of hospital stay of patients not requiring critical care...Continue Reading

References

Jul 9, 1999·Journal of Epidemiology and Community Health·E RegidorJ Alonso
Jul 12, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Kathleen M NeuzilPatrick Heagerty
Mar 17, 2006·Nature
Apr 20, 2006·Vaccine·James Mark SimmermanViroj Tangcharoensathien
Nov 3, 2006·Pediatrics·Ron KerenSusan E Coffin
Jun 5, 2007·Vaccine·Noelle-Angelique M MolinariCarolyn B Bridges
Oct 15, 2008·PharmacoEconomics·Martin Keech, Paul Beardsworth
Jan 30, 2009·Arthritis and Rheumatism·Estibaliz LozaUNKNOWN Artrocad Study Group
Feb 10, 2009·American Journal of Preventive Medicine·Fauziya HassanKevin Dombkowski
Aug 1, 2009·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·B Duncan
Aug 12, 2009·The Lancet Infectious Diseases·Jane BurchLesley Stewart
Sep 19, 2009·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·L BrouwersM Boman
Oct 10, 2009·The New England Journal of Medicine·Steven A R WebbMichael Yung
Dec 10, 2009·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Marcus Richard Keogh-BrownPhilippe Beutels
Dec 17, 2009·BMJ : British Medical Journal·Liam J DonaldsonIain E Yardley
Feb 27, 2010·The European Respiratory Journal·R RiquelmeJ Ramirez
Jun 26, 2010·Vaccine·Gerry FairbrotherUNKNOWN New Vaccine Surveillance Network (NVSN)
Sep 9, 2010·JAMA : the Journal of the American Medical Association·Edward A BelongiaDavid K Shay
Nov 26, 2010·BMC Public Health·Yiting XueBirgitte Freiesleben de Blasio
Mar 19, 2011·The Journal of Infection·Susanna EspositoNicola Principi
Apr 22, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ake OrtqvistBo Svenungsson
Jun 17, 2011·Occupational and Environmental Medicine·Isabel Torá-RocamoraFernando G Benavides
Jul 13, 2011·PloS One·Drosos E KarageorgopoulosMatthew E Falagas
Jul 14, 2011·Revista española de salud pública·Angela DomínguezUNKNOWN Grupo de Trabajo del Proyecto CIBERESP de Casos y Controles sobre la Gripe Pandémica
Apr 3, 2012·The Journal of Antimicrobial Chemotherapy·Miguel Delgado-RodríguezUNKNOWN CIBERESP Cases and Controls in Pandemic Influenza Working Group
Jun 20, 2012·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·B OlowokureH Osman
Nov 3, 2012·Enfermedades infecciosas y microbiología clínica·Amparo Larrauri CámaraUNKNOWN Spanish Influenza Surveillance System (SISS)
Feb 7, 2015·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M JonesI Onakpoya

❮ Previous
Next ❯

Citations

Aug 12, 2014·BMC Public Health·Emmanuelle PreaudSandrine I Samson
Sep 27, 2013·Influenza and Other Respiratory Viruses·Andrea C TriccoSharon E Straus
Sep 27, 2013·Influenza and Other Respiratory Viruses·Naiyana PraditsitthikornYot Teerawattananon
Jan 17, 2013·Human Vaccines & Immunotherapeutics·Sudeep KarveKeith L Davis
Dec 18, 2014·Journal of Medical Internet Research·Dong-Woo SeoSang-Il Lee
May 18, 2016·Human Vaccines & Immunotherapeutics·Amos GarcíaRaúl Morano Larragueta
Jan 26, 2017·Health Economics·Fabian DuarteDavid Powell
Mar 4, 2020·Influenza and Other Respiratory Viruses·Víctor Quirós-GonzálezJosé Mª Eiros
Jul 5, 2012·PloS One·Andrea C TriccoSharon E Straus
Jun 12, 2021·Applied Health Economics and Health Policy·Janetta E SkarpKatharina Hauck
Jun 14, 2021·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Derek HazardMartin Wolkewitz

❮ Previous
Next ❯

Software Mentioned

Excel
SPSS

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.